Literature DB >> 12044245

Three-dimensional conformal radiotherapy for lung cancer: promises and pitfalls.

Rakesh R Patel1, Minesh Mehta.   

Abstract

Lung cancer represents a major source of morbidity and mortality. Despite recent advances, long-term survival remains elusive in most patients with locally advanced cancer. A substantial proportion of these patients experience a relapse at the original site of disease within the thorax, making radiotherapy an important component of treatment. Of several approaches investigated to improve the therapeutic ratio in radiotherapy, three-dimensional conformal radiotherapy holds the most promise, primarily because it allows higher doses to be delivered to the target by improved shaping of radiation portals and conformal avoidance of normal structures. The rationale and evolution of this technology and its potential pitfalls are presented in this review.

Entities:  

Mesh:

Year:  2002        PMID: 12044245     DOI: 10.1007/s11912-002-0011-5

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  32 in total

1.  The use of active breathing control (ABC) to reduce margin for breathing motion.

Authors:  J W Wong; M B Sharpe; D A Jaffray; V R Kini; J M Robertson; J S Stromberg; A A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-01       Impact factor: 7.038

2.  Non-small cell lung tumors repopulate rapidly during radiation therapy.

Authors:  J F Fowler; R Chappell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

3.  Respiration gated radiotherapy treatment: a technical study.

Authors:  H D Kubo; B C Hill
Journal:  Phys Med Biol       Date:  1996-01       Impact factor: 3.609

4.  Conformal radiotherapy of Stage III non-small cell lung cancer: a class solution involving non-coplanar intensity-modulated beams.

Authors:  S Derycke; W R De Gersem; B B Van Duyse; W C De Neve
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-01       Impact factor: 7.038

5.  Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy.

Authors:  T R Mackie; T Holmes; S Swerdloff; P Reckwerdt; J O Deasy; J Yang; B Paliwal; T Kinsella
Journal:  Med Phys       Date:  1993 Nov-Dec       Impact factor: 4.071

6.  Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy.

Authors:  K E Rosenzweig; S E Sim; B Mychalczak; L E Braban; R Schindelheim; S A Leibel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-07-01       Impact factor: 7.038

7.  Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.

Authors:  G S Sibley; T A Jamieson; L B Marks; M S Anscher; L R Prosnitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

8.  Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.

Authors:  W T Sause; C Scott; S Taylor; D Johnson; R Livingston; R Komaki; B Emami; W J Curran; R W Byhardt; A T Turrisi
Journal:  J Natl Cancer Inst       Date:  1995-02-01       Impact factor: 13.506

9.  Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients.

Authors:  T Le Chevalier; R Arriagada; E Quoix; P Ruffie; M Martin; M Tarayre; M J Lacombe-Terrier; J Y Douillard; A Laplanche
Journal:  J Natl Cancer Inst       Date:  1991-03-20       Impact factor: 13.506

10.  Irradiation synchronized with respiration gate.

Authors:  K Ohara; T Okumura; M Akisada; T Inada; T Mori; H Yokota; M J Calaguas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-10       Impact factor: 7.038

View more
  1 in total

1.  An IMRT/VMAT Technique for Nonsmall Cell Lung Cancer.

Authors:  Nan Zhao; Ruijie Yang; Junjie Wang; Xile Zhang; Jinna Li
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.